CEFODIZIME SODIUM PDF

Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Kagami Dole
Country: Eritrea
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 13 November 2013
Pages: 332
PDF File Size: 3.98 Mb
ePub File Size: 13.57 Mb
ISBN: 630-1-69706-479-6
Downloads: 62357
Price: Free* [*Free Regsitration Required]
Uploader: Bashura

Paromomycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Paromomycin. Stavudine The excretion of Stavudine can be decreased when combined with Cefotaxime.

Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotaxime is combined with Risedronate. Certificate of Analysis Catalog Number sc Why create an account? Tiapride Cefotaxime may cdfodizime the excretion rate of Tiapride which could result in a higher serum level.

Click on image or enlarge button to enlarge. Fenofibrate Cefotaxime may decrease the excretion rate of Fenofibrate which could result cefodiizme a higher serum level.

Please provide a valid email address. Neocitrullamon The therapeutic efficacy of Neocitrullamon can be decreased when used in combination with Cffodizime. Clorindione The risk or severity of bleeding can be increased when Cefotaxime is combined with Clorindione. Mepivacaine Cefotaxime may decrease the excretion rate of Mepivacaine which could result in a higher serum level. NS The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with NS Bacillus calmette-guerin substrain danish live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain danish live antigen can be decreased when used in combination with Cefotaxime.

  HALOALKANES HALOARENES NOTES PDF

Darexaban The therapeutic efficacy of Darexaban can be decreased when used in combination with Cefotaxime.

Cefodizime sodium (CAS 86329-79-5)

Lorcaserin Cefotaxime may decrease the excretion rate of Lorcaserin which could result in a higher serum level. Arsenic trioxide Cefotaxime may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.

Fenoldopam Cefotaxime may decrease the excretion rate of Fenoldopam which could result in a higher serum level. Testosterone cypionate Cefotaxime may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.

Brinase The therapeutic efficacy of Brinase can be decreased when used in combination with Cefotaxime.

Cefodizime Sodium

Propiverine Cefotaxime may decrease the excretion rate of Propiverine which could result in a higher serum level. Hydroxocobalamin Cefotaxime may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level. Isotretinoin Cefotaxime may decrease the excretion rate of Isotretinoin which could result in a higher serum level.

Cefpodoxime The risk or severity of sodlum can be increased when Cefotaxime is combined with Cefpodoxime.

Neamine The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Neamine. Megestrol acetate Cefotaxime may decrease the excretion rate of Megestrol acetate which could result in a higher serum level. Allopurinol Cefotaxime may decrease the excretion rate of Allopurinol cfodizime could result in a higher serum level.

  ALQABAS KUWAIT PDF

Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Magnesium salicylate. Gemeprost Cefotaxime may decrease the excretion rate of Gemeprost which could result in a higher serum level.

Ticlopidine Cefotaxime may decrease the excretion rate of Ticlopidine which could result in a higher serum level. Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefotaxime.

KEGG DRUG: Cefodizime sodium

Vigabatrin The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Cefotaxime. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. Hexobarbital The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Cefotaxime. Pentetic acid Cefotaxime may decrease the excretion rate of Pentetic acid which could sodimu in a higher serum level.

Rivaroxaban Cefotaxime may decrease the excretion cefoeizime of Rivaroxaban which could result in a higher serum level. Nifedipine Cefotaxime may decrease the excretion rate of Nifedipine which could result in a higher serum level. Trametinib Cefotaxime may decrease the excretion rate of Trametinib which could result in a higher serum level.

Bupropion Cefotaxime may decrease the excretion rate of Bupropion which could result in a cefodizimee serum level. For Research Use Only.